Latest Listicles

Download this listicle to learn about four cellular senescence studies including the elimination of senescent cells delays tumorigenesis and extends lifespans in mice, senolytic treatment reduces plaque development and increases vasomotor function, implications in Alzheimer's disease and senolytics for kidney disease: a promising preliminary clinical report.

March 8, 2021, marks International Women’s Day, a day to celebrate the achievements of women around the world. It is a day that Technology Networks acknowledges each year, in efforts to share the triumphs achieved and challenges faced by women working in science.

Inductively coupled plasma mass spectrometry (ICP-MS) can be used for a broad range of applications. Download this listicle to learn about the applications of ICP-MS, for example, its use in forensic science and law enforcement.

Download this listicle to learn about key approaches, challenges and advances in gene therapy.

This listicle highlights five changes spurred by COVID-19 that will continue to transform modern laboratories in 2021 and beyond.

In this listicle, we will discuss the principles of FBDD, how it compares to other drug discovery approaches, as well as highlighting various techniques that allow for lead compound identification with FBDD.

This listicle details the top 10 most-read non-COVID-19 cancer research news stories from the field this year, published on Technology Networks.

Cell culture has been advancing biological and biomedical research since the first cell line was established in the late 1940s. In this listicle, explore various 3D cell culture formats and key research areas that have harnessed 3D cultures.

This listicle addresses advances in dementia research over 2020, highlighting the strides science has made in diagnosis and treatment development.

In cancer, rapidly emerging evidence suggests that the microbiome influences disease progression in a myriad of direct and indirect ways. In this listicle, we look at recent research developments directed towards exploring the emerging “oncomicrobiome”.